River 3 Renal Corp.

River 3 Renal Corp. focuses on clinical research in Alport syndrome and primary steroid-resistant focal segmental glomerulosclerosis, with attention to renal disorders that cause progressive loss of kidney function and persistent proteinuria.

• Alport syndrome
• Primary steroid-resistant focal segmental glomerulosclerosis
• Proteinuria

The sponsor’s research activity in these conditions reflects a concentrated interest in nephrology and disease areas marked by hereditary and structural kidney pathology.